Biotech RadarJobs updated

COMPANY

Flare Therapeutics

HQ: Cambridge, MA source · flaretx.com ↗ · New England

Clinical Phase 1

1 open job · last seen Oct 23, 2026 · 6 sources

Keywords: small molecule oncology Metastatic Castration Resistant Prostate Cancer mCRPC mCRPC (Metastatic Castration-resistant Prostate Cancer) Prostatic Neoplasms Castration-Resistant Prostatic Neoplasms mCRPC or Advanced/Metastatic Solid Tumors mCRPC, Metastatic Castration Resistant Prostate Cancer Neoplasms Prostate Neoplasms of Prostate Advanced Urothelial Carcinoma Oral Drug Administration FX-111 FX-909

Profile checked Oct 10, 2026

Since the raise (Jun 30, 2026): 1 of 1 open job was first seen after it.

1Open jobs$85.0MRaised (2 yrs)2Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Don't see an opening for you? Apply anyways!Cambridge, MassachusettsMay 12, 2021Oct 8, 2026

See all 1 job

Raises and deals from press releases

Raises announced in these releases: $85M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Board tracked Radar started tracking this company’s job board (1 open job at last check). source ↗
  2. Trial start Phase 1: A Study in Patients With Metastatic Castration-Resistant Prostate Cancer source ↗
  3. Raise Private equity round — Series C: $85M (total, as published), announced Jun 30, 2026. Source: company's own press page. source ↗
  4. Raise Series C · $85M source ↗
  5. Partnership Partnership / licensing announced Oct 21, 2025. Source: company's own press page. source ↗
  6. Partnership Partnership / licensing announced Nov 12, 2024. Source: company's own press page. source ↗
  7. Trial start Phase 1: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 1

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Don't see an opening for you? Apply anyways!Cambridge, MassachusettsMay 12, 2021Oct 8, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $85.0M. Last 2 years.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07719361A Study in Patients With Metastatic Castration-Resistant Prostate CancerPhase 1RecruitingJul 1, 2026Feb 15, 2028 (estimated)
NCT05929235A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaPhase 1Active, not recruitingAug 24, 2023Oct 30, 2027 (estimated)

Connect

See your connections at Flare Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback